Patents by Inventor Patrick J. Frenchick

Patrick J. Frenchick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VARICELLA ZOSTER
    Publication number: 20220409721
    Abstract: The present application relates to compositions capable of inducing an immune response against Varicella zoster virus, methods of administering such compositions, and methods of producing such compositions.
    Type: Application
    Filed: November 4, 2020
    Publication date: December 29, 2022
    Applicant: ADJUVANCE TECHNOLOGIES, INC.
    Inventors: J Tyler MARTIN, Jared William WENGER, Eric Jon FARRIS, Patrick J FRENCHICK (Deceased), Anna Therese LAMPE
  • Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine
    Patent number: 6270800
    Abstract: A microencapsulated subunit component from bovine herpes virus-1 (BHV-1) is disclosed. Vaccines, kits, and methods for using the same to vaccinate a member of a bovine species are also disclosed.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: August 7, 2001
    Assignee: Pfizer Inc.
    Inventors: Tully J. Speaker, H. Fred Clark, Charlotte A. Moser, Paul A. Offit, Manuel Campos, Patrick J. Frenchick
  • Adjuvants for vaccines against respiratory syncytial virus
    Patent number: 5723130
    Abstract: Vaccine formulations and therapeutic methods therefor containing respiratory syncytial viral proteins or immunological fragment and an adjuvant selected from the group consisting of QS-21 3-deacylated monophosphoryl lipid A, monopohosphoryl lipid A and combination are described herein. Presence of the adjuvant(s) significantly increases the humoral and cell-mediated immunogenicity of the RSV proteins.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: March 3, 1998
    Inventors: Gerald E. Hancock, Dan J. Speelman, Patrick J. Frenchick
  • Rotavirus nucleocapsid protein VP6 in vaccine compositions
    Patent number: 5374426
    Abstract: Immunological carrier complexes are provided utilizing the VP6 polypeptide from rotavirus as the carrier molecule. Also provided are methods of binding epitope-bearing molecules (e.g., haptens) to the VP6 carrier molecule through binding peptides. The VP6 carrier can be a VP6 monomer, oligomer, or a particle.
    Type: Grant
    Filed: October 30, 1989
    Date of Patent: December 20, 1994
    Assignee: University of Saskatchewan
    Inventors: Marta I. Sabara, Patrick J. Frenchick, Kerry F. Mullin-Ready
  • Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions
    Patent number: 5071651
    Abstract: Immunological carrier complexes are provided utilizing the VP6 polypeptide from rotavirus as the carrier molecule. Also provided are methods of binding epitope-bearing molecules (e.g., haptens) to the VP6 carrier molecule through binding peptides. The VP6 carrier can be a VP6 monomer, oligomer, or a particle containing of VP6 oligomers.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: December 10, 1991
    Assignee: University of Saskatchewan
    Inventors: Marta I. Sabara, Patrick J. Frenchick, Kerry F. Mullin-Ready